ReviewMethodsX2026
Comparative Analysis of Deep Learning Techniques in Alzheimer's Disease Diagnosis: Trends, Challenges, and Future Directions.
Review in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease is a slow, progressive neurological disorder that impacts the brain tissue and causes cells to die, the most common reason for dementia. It typically reduces brain volume, subsequently impairing several cognitive functions. We explored the phases of Alzheimer's disease diagnosis by thoroughly analysing the paper and highlighting the significance of pre-processing methods. Artificial intelligence progress has transformed medical image analysis by enabling automatic, precise identification of Alzheimer's disease through hybrid architectures, convolutional neural networks, and transfer-learning-based models. This article includes applications of Alzheimer's disease based on datasets, Artificial Intelligence models, limitations, pre-processing methods, challenges, and current research in this area. The article lists various medicinal modalities, risk factors for Alzheimer's disease, the disease's progression stages, and different criteria for evaluating the performance of Artificial Intelligence models. Accuracy, precision, confusion matrix, AUC, F1-score, ROC, recall, and MCC are some of the metrics covered in this paper. The paper discusses the number of comparisons of various deep learning techniques for Alzheimer's, new trends, limitations, recommendations, and future directions. Finally, the paper shows the ongoing practical outcomes and difficulties in Alzheimer's situations. Building on the analysis, this survey helps to cover different dimensions of Alzheimer's disease that have not been previously considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.